NSEGeneral Updates30 Jun 2026 · 30 Jun 2026, 11:54 am
General Updates
Mankind Pharma Limited · MANKIND
✦ AI SummaryResults
Mankind Pharma Limited has scheduled its 35th Annual General Meeting (AGM) on August 4, 2026, through video conferencing. The notice and annual report for the financial year 2025-26 will be dispatched to members in due course.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
MANKIND1_30062026115440_Intimation_of_AGM_sd.pdf
View document text
June 30, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543904 Symbol: Mankind
Dear Sir/ Madam,
Subject: Intimation of the date of Thirty Fifth (35th) Annual General Meeting of the
Company
With reference to the captioned subject, we wish to inform you that the 35th Annual General
Meeting (“AGM”) of the Members of Mankind Pharma Limited (“the Company”) is scheduled
to be held on Tuesday, August 4, 2026 at 03:30 p.m. (IST) through Video Conferencing/ Other
Audio-Visual Means in compliance with the applicable provisions of the Companies Act, 2013
(the “Act”) and the relevant circulars issued by the Ministry of Corporate Affairs and the
Securities and Exchange Board of India.
Kindly note that Notice of the AGM along with Annual Report for the financial year 2025-26
will be dispatched to the Members in due course in compliance with the applicable provisions
of the Act, relevant circulars and Listing Regulations.
Above information shall also be available on the website of the Company i.e.
www.mankindpharma.com.
You are requested to take the above information on your record.
Thanking You,
Yours Sincerely,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer